Buy & Sell Abbott Laboratories (ABT) – Abbott Laboratories Price Today
Aura AI Summary
Key Stats
- $154.71BMarket Cap
- HealthSector
- -29.01%3M Drawdown
- $181.46BEnterprise Value
- 2.84%Dividend Yield
- 79% Buy | 21% SellTrading Activity
- 95 daysTypical Hold Time
Abbott Laboratories (ABT) is currently valued at a market capitalization of $154.71B, with an enterprise value of $181.46B. Over the past 52 weeks, Abbott Laboratories has traded between a low of $82.57 and a high of $138.08, highlighting its annual price range. Over the past three months, Abbott Laboratories has recorded a drawdown of -29.01%, reflecting recent price volatility. Abbott Laboratories offers a dividend yield of 2.84%, with the most recent dividend of $0.63 paid on 15 Apr 26. On average, investors hold Abbott Laboratories for approximately 95 days, indicating typical investor behavior on the platform.
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Most Recent News
Global Water Awards 2026 winners announced, highlighting innovations in water tech and sustainability.
The 2026 Global Water Awards were announced on May 19 during the Global Water Summit, recognizing top companies and projects in water technology and sustainability. New categories included AI Project of the Year and separate awards for industrial and...

In-flight retail and advertising market to hit $5.9B by 2032, driven by AI and personalized shopping tech
The global in-flight retail and advertising market is projected to grow from $3.4 billion in 2025 to $5.9 billion by 2032, with an 8.2% CAGR. Growth is fueled by technological advances such as AI-driven personalized ads, mobile shopping, and augmente...

Investec Bank discloses share dealings in NCC Group amid takeover code compliance.
Investec Bank plc, acting as joint broker to NCC Group plc, disclosed its purchase and sale of 423,993 ordinary shares on May 19, 2026. The transactions were carried out within a price range of approximately 140.14 to 140.9 per share. These dealings ...
